Drug Topics
NOVEMBER 17, 2023
Women with endometriosis face an average of 7 to 11 years between the time of symptom onset and diagnosis, during which they experience increased symptoms, hospitalizations, and health care resource utilization.
Pharmacy Times
NOVEMBER 17, 2023
In this multi-part series on burnout and the problems currently facing pharmacy, trauma-informed pharmacist Helen Sairany, PharmD, MBA, discusses why burnout is skyrocketing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 17, 2023
Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero? Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass.
Pharmacy Times
NOVEMBER 17, 2023
Not only is the test significant for identifying HIV and TB, but it can be safer for patients living with HIV due to their suppressed immune systems.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 17, 2023
Flu activity in many parts of the United States is starting to rise more rapidly, signaling that flu season is on the horizon, the Centers for Disease Control and Prevention reported Friday. With Americans set to travel for Thanksgiving gatherings next week, people who’ve been waiting to get a flu shot should think about acting now, Alicia Budd, the CDC’s team lead for domestic flu surveillance, told STAT.
Pharmacy Times
NOVEMBER 17, 2023
Lisa Deschamps, CEO of AviadoBio, discusses frontotemporal dementia and AVB-101, a one-time therapy designed to stop disease progression by delivering a functional copy of the GRN gene and restoring progranulin levels in the brain.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
NOVEMBER 17, 2023
As the industry continues to debate the promise and risks of artificial intelligence in healthcare, patients are bullish on the potential for generative AI to improve access and even lower healthca | As the industry continues to debate the promise and risks of artificial intelligence in healthcare, patients are bullish on the potential for generative AI to improve access and even lower healthcare costs.
STAT
NOVEMBER 17, 2023
The Food and Drug Administration has approved a Medtronic device to lower blood pressure, the company announced Friday evening. The decision comes after an advisory panel narrowly voted against the device in August. The FDA approved a similar product, part of a device class called renal denervation, from startup Recor Medical earlier this month. “Medtronic has always believed in the potential of this therapy,” Jason Weidman, renal denervation head at Medtronic, said in a statement.
Pharmacy Times
NOVEMBER 17, 2023
The acceptance comes after results from TRANSCEND CLL 004, which is the first trial to demonstrate clinical benefit with a CAR T cell therapy in patients who were previously treated for CLL or SLL.
STAT
NOVEMBER 17, 2023
WASHINGTON — Doctors are splitting, specialty by specialty, over whether and how to overhaul a secretive panel that helps determine how much Medicare pays them for their work. Doctors who get paid more by Medicare generally like the way the panel operates now. But doctors who are paid relatively less are looking for ways they say would make the process more fair.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
NOVEMBER 17, 2023
The products include Doxycycline Hyclate Delayed-Release Tablets, Lisdexamfetamine Dimesylate Capsules, Calcium Gluconate in Sodium Chloride Injection, Estradiol Tablets USP
Fierce Pharma
NOVEMBER 17, 2023
The FDA has signed off on label expansions for two of the world’s most important cancer medicines—Merck’s Keytruda and Pfizer and Astellas’ Xtandi. | The FDA has signed off on label expansions for two of the world’s most important cancer medicines—Merck’s Keytruda and Pfizer and Astellas’ Xtandi. Keytruda’s expansion is in stomach cancer. Xtandi’s new indication expands its already deep portfolio in the treatment of prostate cancer.
Fierce Healthcare
NOVEMBER 17, 2023
A coalition including the NAACP and other civil rights organizations released a scorecard Thursday grading each state on its policies handling the Medicaid unwinding period. | Just one state received a passing score on Medicaid redeterminations from a coalition of nationally recognized civil rights groups.
STAT
NOVEMBER 17, 2023
This article is part of a partnership between First Opinion and Tradeoffs, a nonprofit news organization exploring our confusing, costly, and often counterintuitive health care system. To learn more about how ransomware hurts hospitals and patients, listen to a deeper dive from Tradeoffs, and subscribe to never miss an episode.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
NOVEMBER 17, 2023
The Federal Trade Commission (FTC) has stepped in to block a California hospital deal it said will result in less competition and higher healthcare costs. | A federal and state investigation concluded that the deal for San Ramon Regional Medical Center would give John Muir Health over 50% of the local inpatient general acute care market, likely leading to higher prices and lower quality in the area.
STAT
NOVEMBER 17, 2023
Gathering health data remotely is a pain. Forgetting to slip on a wearable is easy, and hooking yourself up to a large monitor is intrusive. Celero Systems has another idea: What if your remote patient monitor was small enough to swallow? A team of researchers has tested Celero’s device in humans for the first time, successfully capturing heart and respiratory data in 10 patients with sleep apnea.
Fierce Pharma
NOVEMBER 17, 2023
Amid a corporate review of AstraZeneca’s global manufacturing and supply network, the company’s Indian subsidiary is planning to close up shop at the “beating heart” of its India operations in Bang | AstraZeneca Pharma India will exit its production plant in Bangalore, India, “in due course,” the company said in a filing. AZ plans to find a buyer who can also serve as a contract manufacturer for the drugs produced there.
Drug Topics
NOVEMBER 17, 2023
Zonisamide has a role in the treatment of epilepsy and is being explored in other central nervous system disorders.
Fierce Pharma
NOVEMBER 17, 2023
After the landmark success of Enhertu in HER2-low breast cancer, AstraZeneca has blazed another trail in the world’s most common cancer type. | After the landmark success of Enhertu in HER2-low breast cancer, AstraZeneca has blazed another trail in the world’s most common cancer type. But an unexpected restriction has cast a dark cloud over the first-in-class approval.
STAT
NOVEMBER 17, 2023
WASHINGTON — President Biden on Friday said he plans to appoint cancer researcher and doctor Kimryn Rathmell to lead the National Cancer Institute. Rathmell will assume leadership of the $7.3 billion agency amid the administration’s efforts to relaunch Biden’s Cancer Moonshot initiative with an emphasis on screening, prevention, and better treatment.
Fierce Healthcare
NOVEMBER 17, 2023
Tenet Healthcare has cut a deal with Novant Health to sell off three South Carolina hospitals and their related operations for roughly $2.4 billion, the systems announced Friday morning. | The deal leaves Tenet with after-tax proceeds of $1.75 billion, which it said it will primarily use for debt retirement. The systems said they'll remain partners for ambulatory surgery and revenue cycle management in the affected markets.
STAT
NOVEMBER 17, 2023
And so, another working week will soon draw to a close Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. Besides the usual promenading with the official mascots, we hope to catch up on our reading and manicure the Pharmalot grounds. We may also have time for a listening party with a rotation that would likely include this , this , this , and this.
Drug Store News
NOVEMBER 17, 2023
Award winners from the 2023 ceremony can share and save high-resolution photos from the exciting night celebrating their accomplishments and contributions to the industry.
Fierce Pharma
NOVEMBER 17, 2023
As Daiichi Sankyo holds out for local approval of its omicron-adapted mRNA shot for COVID-19, the company has struck up a major supply pact in its native Japan. | Daiichi Sankyo has reached an agreement with Japan’s Ministry of Health, Labor and Welfare (MHLW) to supply its shot—coded DS-5670—for a vaccination program against COVID that kicked off this fall.
Pharmaceutical Technology
NOVEMBER 17, 2023
Micron Biomedical has received $23.6m in funding from the Bill & Melinda Gates Foundation for the bulk manufacturing of needle-free vaccines.
Pharmacy Times
NOVEMBER 17, 2023
The approval makes pembrolizumab the first-line treatment for individuals with this cancer.
The Checkup by Singlecare
NOVEMBER 17, 2023
Some cultures have superstitions regarding itchy palms. Some believe itchy palms indicate good fortune is in your future. However, several health conditions could be the real reasons behind your itchiness. Depending on what is causing you to itch, you may notice other symptoms like runny nose, rashes, or flaking skin. While itchy palms are often caused by something that will go away independently or with simple treatment, some reasons indicate a more serious health condition.
Pharmacy Times
NOVEMBER 17, 2023
The legal and common uses of “interchangeability” continue to be conflated.
PharmaVoice
NOVEMBER 17, 2023
The recently observed dip was particularly acute for men, who now live an average of 5.8 fewer years than women.
Fierce Healthcare
NOVEMBER 17, 2023
There are plenty of lessons to be learned in failure, but it's rare for a company and its top brass to offer a peak behind the curtain into those takeaways. | There are plenty of lessons to be learned in failure, but it's rare for a company and its top brass to offer a peak behind the curtain into those takeaways.
STAT
NOVEMBER 17, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a deep dive on a historic moment for genome editing, mixology tips from a biotech lifer, and a look at why scientists are interested in muscle-building drugs.
European Pharmaceutical Review
NOVEMBER 17, 2023
The European Commission has approved Ebglyss (lebrikizumab) for atopic dermatitis patients 12 years and older with a body weight of at least 40kg, who are candidates for systemic therapy. Almirall has licensed the rights to develop and commercialise lebrikizumab for the treatment of dermatology indications in Europe. The company said it will launch lebrikizumab in Germany, with further European rollout planned throughout 2024.
Drug Store News
NOVEMBER 17, 2023
Drug Store News celebrates the women making their mark in retail pharmacy with the fifth annual awards program.
Pharmaceutical Commerce
NOVEMBER 17, 2023
With new mandates right around the corner, there is an unwavering demand for pharma operations to perform at peak efficieny.
Expert insights. Personalized for you.
187 
Let's personalize your content